EDIT - CIK 0001650664
The table below shows Editas Medicine, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $146.65M | $131.54M | $123.65M | $141.52M | $203.52M | $139.68M |
| Short-term investments | $0.00 | $138.37M | $199.46M | $202.75M | $296.33M | $262.43M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $163.90M |
| $289.31M |
| $340.83M |
| $356.75M |
| $507.31M |
| $419.09M |
| Property, plant & equipment | $3.54M | $14.50M | $12.03M | $15.57M | $17.12M | $14.02M |
| Goodwill | - | - | - | - | - | - |
| Total assets | $186.53M | $341.59M | $499.15M | $514.32M | $677.48M | $572.60M |
| Accounts payable | $2.60M | $5.49M | $8.27M | $9.51M | $5.05M | $6.41M |
| Total current liabilities | $46.25M | $77.22M | $63.22M | $60.11M | $46.88M | $58.21M |
| Long-term debt | $53.60M | $52.43M | - | - | - | - |
| Total liabilities | $159.25M | $207.31M | $150.06M | $153.64M | $123.84M | $179.02M |
| Retained earnings | -$1.63B | -$1.47B | -$1.23B | -$1.08B | -$857.70M | -$665.20M |
| Total equity | $27.29M | $134.27M | $349.10M | $360.68M | $553.64M | $393.59M |